Your browser doesn't support javascript.
loading
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions.
Scholte, F E M; Karaaslan, E; O'Neal, T J; Sorvillo, T E; Genzer, S C; Welch, S R; Coleman-McCray, J D; Spengler, J R; Kainulainen, M H; Montgomery, J M; Pegan, S D; Bergeron, E; Spiropoulou, C F.
Afiliação
  • Scholte FEM; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Karaaslan E; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • O'Neal TJ; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA, United States.
  • Sorvillo TE; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Genzer SC; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Welch SR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Coleman-McCray JD; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Spengler JR; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Kainulainen MH; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Montgomery JM; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Pegan SD; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
  • Bergeron E; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA, United States.
  • Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens & Pathology, Centers for Disease Control & Prevention, Atlanta, GA, United States.
Front Cell Infect Microbiol ; 13: 1233148, 2023.
Article em En | MEDLINE | ID: mdl-37671145

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vírus da Febre Hemorrágica da Crimeia-Congo Limite: Animals / Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Vírus da Febre Hemorrágica da Crimeia-Congo Limite: Animals / Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça